FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

ERIS Share Price Discussion

Eris Lifesciences Ltd.
NSE: ERIS | BSE: 540596 | ISIN: INE406M01024 | Sector: Pharmaceuticals and health care

ERIS Rating

4/5 (3 Ratings)
ERIS Share Price *
466.5 -58.5 (-11.14%)
* (quote may be delayed)
Find answers to all your questions on live ERIS message board: Is ERIS buy or sell? Should I buy ERIS shares? Why are ERIS shares falling? Should I invest in ERIS stock?

You can also check ERIS share price target recommended by brokerages.

ERIS Discussion Forum

@tradingfab • Reputation: 815
Sameer in ERIS
08-01-20 BUY ERIS --> NSE(Positional) Only Abo...

Hit 515 🔥🔥💥🚀🚀🚀
Like
reply
Reply
@tradingfab • Reputation: 815
Sameer in ERIS
08-01-20 BUY ERIS --> NSE(Positional) Only Abo...

ERIS - Hit 505 🔥🔥🔥🚀🚀🚀
Like
reply
Reply
@RUDRA007 • Reputation: 2,518

BUY ERIS LIFE ABOVE 503,, STOPLOSS OF 465 ON CLOSING,, FOR TARGETS OF 560-600-640,, INVESTMENT IDEA
Like
reply
Reply
@tradingfab • Reputation: 815

08-01-20
BUY ERIS --> NSE(Positional)
Only Above @ 495.30
SL 475
TGT 505, 515, 525
Like
reply
Reply (3)
Latest replies
Sameer  @tradingfab
Jan 9 3:17 PM

ERIS - Today's High 500 🔥🔥
Sameer  @tradingfab
Jan 9 3:51 PM

ERIS - Hit 505 🔥🔥🔥🚀🚀🚀
Sameer  @tradingfab
Jan 10 4:59 PM

Hit 515 🔥🔥💥🚀🚀🚀
@TTA • Reputation: 9,205

ERIS LIFESCIENCES: CO PROPOSED OFFER FOR BUYBACK OF UP TO 1.74M SHARES AT A PRICE OF RS. 575/SHARE
Like
reply
Reply
@ashishjshah • Reputation: 1,006

BTST CASH ERIS LIFE 472 SL 460 TGT 488, 500++
Like
reply
Reply
@invictotrader • Reputation: 2,808

Eris Lifesciences buys anti-diabetes novel drug Zomelis in India for US$ 13 million
Like
reply
Reply
@TTA • Reputation: 9,205

CS On Eris Life
OP, TP Rs 595
Vildagliptin Patents Expiring Next Week (Dec 9)
Vilda One Of Key Growth Drivers For FY21
Post Patent Expiry Expect Vilda Market To Expand In Vols
Expect Competition To Be Fierce Post Generics Entry In Vilda
Like
reply
Reply
@invictotrader • Reputation: 2,808

Eris Lifesciences buys vildagliptin brand Zomelis from Novartis for $13 million Eris added that it will start selling the product in the Indian market from December 10 onwards.
Like
reply
Reply
@Technicalcasinoclub • Reputation: 22,709
The Inside Guy in ERIS
Buy Eris life sciences at cmp 446 btst Amount ...

Target hits (460) +15 👍🏻 *Book and exit*
Like
reply
Reply
@Technicalcasinoclub • Reputation: 22,709
The Inside Guy in ERIS
Buy Eris life sciences at cmp 446 btst Amount ...

455 (+9) Book half
target 460
Like
reply
Reply
@Technicalcasinoclub • Reputation: 22,709

Buy Eris life sciences at cmp 446 btst
Amount 10000/-
Like
reply
Reply (2)
Latest replies

20 shares.
Stoploss/tgt tommorow

High 473 booked 🤑
@databot • Reputation: 1,630

Prabhudas Lilladher target on ERIS
Date: 21-Nov-19 Broker: Prabhudas Lilladher Price @ Call: 415.24 Target: 459 Recommendation: ACCUMULATE
Like
reply
Reply
@umanath • Reputation: 563

ERIS - 430360

Like
reply
Reply
@databot • Reputation: 1,630

Prabhudas Lilladher target on ERIS
Date: 07-Nov-19 Broker: Prabhudas Lilladher Price @ Call: 422.67 Target: 459 Recommendation: ACCUMULATE
Like
reply
Reply
@newsbot • Reputation: 2,292
Accumulate Eris Lifesciences; target of Rs 459: Prabhudas Lilladher
Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 459 in its research report dated July 29, 2019.
www.moneycontrol.com
Like
reply
Reply
@newsbot • Reputation: 2,292
Eris Life Standalone June 2019 Net Sales at Rs 262.33 crore, up 15.82% Y-o-Y
moneycontrol.com
Like
reply
Reply
@newsbot • Reputation: 2,292
Stocks in the news: ICICI Bank, Cadila Health, Mahindra Life, Vedanta, Uflex, Granules, NHPC
Maruti Suzuki | Allahabad Bank | Future Lifestyle Fashions | ICICI Bank | Power Mech Projects | Manpasand Beverages and Usha Martin are stocks which are in news today.
www.moneycontrol.com
Like
reply
Reply
@newsbot • Reputation: 2,292
Like
reply
Reply
@newsbot • Reputation: 2,292
Like
reply
Reply
@newsbot • Reputation: 2,292
Like
reply
Reply
@newsbot • Reputation: 2,292
Like
reply
Reply
@newsbot • Reputation: 2,292
Like
reply
Reply
@newsbot • Reputation: 2,292
Like
reply
Reply
@newsbot • Reputation: 2,292
Like
reply
Reply
@newsbot • Reputation: 2,292
Like
reply
Reply
@newsbot • Reputation: 2,292
Like
reply
Reply
@newsbot • Reputation: 2,292
Like
reply
Reply
@newsbot • Reputation: 2,292
Like
reply
Reply
@newsbot • Reputation: 2,292
Like
reply
Reply
@newsbot • Reputation: 2,292
Like
reply
Reply
@newsbot • Reputation: 2,292
Like
reply
Reply
@newsbot • Reputation: 2,292
Like
reply
Reply
@newsbot • Reputation: 2,292
Like
reply
Reply
  • ERIS - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization8,855.69
    Enterprise Value8,849.22
    Price to Earnings37.17
    Price to Book Value7.66
    Return on Capital Employed0.26
    Return on Equity0.34
    Face Value1
    Dividend YieldNA
  • ERIS Share Price - Technicals

    keyboard_arrow_down
    ERIS - 52 Week High₹660
    ERIS - 52 Week Low₹358.1
  • ERIS - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    21-Nov-19Prabhudas LilladherAccumulate459
    7-Nov-19Prabhudas LilladherAccumulate459
    29-Jul-19Prabhudas LilladherAccumulate459
    30-Jan-19Prabhudas LilladherAccumulate695
    6-Nov-18Prabhudas LilladherAccumulate704
    ERIS Brokerage Price Target
  • ERIS Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Feb 14523525.8451.35465.5
    Feb 13529.55530.2521.05525
    Feb 12528.9534.3515529.55
    Feb 11508.9531505.2524.05
    Feb 10519.75519.75495.5503.5
  • ERIS Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹513.41
    30 Day Moving Average₹508.89
    50 Day Moving Average₹495
    100 Day Moving Average₹461.65
    200 Day Moving Average₹470.14
  • ERIS - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue761688.370.11
    Operating Profit316270.450.17
    Profit Before Tax312266.230.17
    Net Income294242.570.21
  • ERIS - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds1,1568680.33
    Total Liabilities314528-0.41
    Total Assets1,4701,3970.05
  • ERIS - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity236185.170.27
    Cash from Investing Activity-593-174.132.41
    Cash from Financing Activity363-17.52-21.72
    Net Cash Flow7-6.48-2.08
  • ERIS - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.210.39
    Return on Equity0.340.44
    Return on Capital Employed0.260.49
  • ERIS - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.39
    3 Year CAGR Growth in Operating Profit1.78
    3 Year CAGR Growth in EBIDTA1.93
    3 Year CAGR Growth in Net Income2.53
    3 Yr CAGR Growth - Diluted EPS-0.96
  • ERIS - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.82
    5 Year CAGR Growth in Operating Profit2.45
    5 Year CAGR Growth in EBIDTA2.69
    5 Year CAGR Growth in Net Income3.47
    3 Yr CAGR Growth - Diluted EPS-0.95
  • ERIS - Recent News

    keyboard_arrow_down
    NewsBot
    Jul 31 5:08 PM
    Accumulate Eris Lifesciences; target of Rs 459: Prabhudas Lilladher
    www.moneycontrol.com
    NewsBot
    Jul 29 6:33 PM
    Eris Life Standalone June 2019 Net Sales at Rs 262.33 crore, up 15.82% Y-o-Y
    moneycontrol.com
    NewsBot
    Jul 29 2:13 PM
    Stocks in the news: ICICI Bank, Cadila Health, Mahindra Life, Vedanta, Uflex, Granules, NHPC
    www.moneycontrol.com
    NewsBot
    Jul 22 12:48 AM
    NewsBot
    Jul 12 10:33 PM
    NewsBot
    Jun 25 3:08 PM
    NewsBot
    Jun 25 1:13 PM
    NewsBot
    Jun 17 12:58 AM
    NewsBot
    May 22 1:18 PM
    NewsBot
    May 22 12:58 AM
  • ERIS - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. S...
    Aurobindo Pharma Ltd. Sector: Pharma...
    Biocon Ltd. Sector: Pharmaceuticals ...
    Cipla Ltd. Sector: Pharmaceuticals a...
    Dr. Reddy's Laboratories Ltd. Sector...
    Lupin Ltd. Sector: Pharmaceuticals an...
    Piramal Enterprises Ltd. Sector: Phar...
    Divi's Laboratories Ltd. Sector: Pha...
    Glenmark Pharmaceuticals Ltd. Sector...
    Strides Pharma Science Ltd. Sector: P...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.